Literature DB >> 16935171

Congenital cholesteatoma clinical features and surgical results.

Hiromi Kojima1, Yasuhiro Tanaka, Masanori Shiwa, Yuika Sakurai, Hiroshi Moriyama.   

Abstract

We analyzed congenital cholesteatomas in 63 ears of 63 patients who were operated on over a 24-year period. We investigated the presenting symptoms, tympanic membrane findings, cholesteatoma morphology and location, associated anomalies of the ossicles, surgical methods, and outcome of treatment. The age of the patients ranged from 2 to 51 years (mean, 13.3 years), and the closed type of cholesteatoma and the open type were found in 57 ears and 6 ears, respectively. Seventy-three percent of the patients were 15 years or younger. Hearing loss was complained of as a presenting symptom by 60.3% of the patients. In particular, all the patients with the open type of cholesteatoma reported hearing loss as a chief complaint, and most of them had a normal tympanic membrane. Many of the cholesteatomas were located at or around the posterosuperior part of the tympanic cavity. The lesion was confined to the tympanic cavity in 26 (41.3%) ears and to the petrous apex in 1 (1.6%) ear. Advanced cholesteatoma that extended from the tympanic cavity into the mastoid antrum was seen in 35 (55.6%) ears, and multiple cholesteatoma was present in 1 (1.6%) ear. Associated anomalies of the ossicles were suspected in 8 (12.7%) of the 63 ears. Among patients with the open type of cholesteatoma, such anomalies were found in 3 (50.0%) of 6 ears. The super structure of the stapes was destroyed in 63.5% of the patients, so the columella on the foot plate method was most frequently used for ossiculoplasty, followed by the columella on the stapes method and the Wullstein type I method.

Entities:  

Mesh:

Year:  2006        PMID: 16935171     DOI: 10.1016/j.amjoto.2005.11.016

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  8 in total

1.  Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.

Authors:  Yuka Morita; Yutaka Yamamoto; Shinsuke Oshima; Kuniyuki Takahashi; Sugata Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

2.  Congenital cholesteatoma: Different clinical presentation in two cases.

Authors:  S Abdul Jalil; M K Md Daud
Journal:  Malays Fam Physician       Date:  2016-08-31

3.  Clinical Characteristics and Treatment Outcomes of Congenital Cholesteatoma.

Authors:  In Sik Song; Won Gue Han; Kang Hyeon Lim; Kuk Jin Nam; Myung Hoon Yoo; Yoon Chan Rah; June Choi
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

4.  Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.

Authors:  Dong Wook Lee; Jae Ho Chung; Seung Hwan Lee; Chul Won Park; Sung-Ho Kang; Young Ha Oh; Ju Yeon Pyo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

5.  Congenital Cholesteatoma of Temporal Bone with Bezold's Abscess: Case Report.

Authors:  Nara Janardhan; Janardhan Nara; Indeevar Peram; Suresh Palukuri; Arunkumar Chinta; Kuldeep Satna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

6.  Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis.

Authors:  Nelson Gilberto; Sara Custódio; Tiago Colaço; Ricardo Santos; Pedro Sousa; Pedro Escada
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-18       Impact factor: 2.503

7.  Atypical presentation of congenital cholesteatoma in an adult case with good hearing result.

Authors:  Fevzi Solmaz; Davut Akduman; Mehmet Haksever; Ercan Gündoğdu; Atilla Mescioğlu
Journal:  Ann Med Surg (Lond)       Date:  2015-01-17

8.  Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma.

Authors:  Joo Hyun Park; Jungmin Ahn; Il Joon Moon
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-06-27       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.